EMA Backs First FcRn Inhibitor for Myasthenia Gravis – Medscape

  1. EMA Backs First FcRn Inhibitor for Myasthenia Gravis  Medscape
  2. JnJ gets positive CHMP opinion of nipocalimab for antibody-positive patients living with generalised…  Medical Dialogues
  3. Johnson & Johnson Stock (JNJ) Gains on Early EU Nod for Drug…

Continue Reading